{
 "context": "The following article called 'Hercules Technology grants $4.5mm loan to Immune Pharmaceuticals; $5mm more available' was published on 2015-08-06. The body of the article is as follows:\n    \nHercules Technology grants $4.5mm loan to Immune Pharmaceuticals ; $5mm more available Deal Date: Jul-01-2015 / Deal # 201530609 Executive Summary \nHercules Technology Growth Capital issued Immune Pharmaceuticals Inc. (treatments for cancer and inflammatory diseases) a $4.5mm term loan, with an additional $5mm available to the company before June 15, 2016, subject to certain clinical milestones and other events. The loan carries interest at a rate that is the greater of 10% and the prime rate plus 5.25%, and is payable interest-only for the first 18 months.\n\n    The day before the article was published, the stock price of Hercules Technology Growth Capital, Inc. was 5.87202262878418 and the day after the article was published, the stock price of Hercules Technology Growth Capital, Inc. was ",
 "expected": "6.2390241622924805",
 "date": "2015-08-06",
 "ticker": "HTGC",
 "company": "Hercules Technology Growth Capital, Inc."
}